Cargando…
Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self‐management
BACKGROUND: Congenital adrenal hyperplasia (CAH) is caused by a deficiency of one of the enzymes required for cortisol biosynthesis. The disease is classified as either classic (severe phenotype), subdivided into simple virilizing (SV) and salt‐wasting (SW), or non‐classic (NC) CAH. The treatment re...
Autores principales: | Ekbom, Kerstin, Strandqvist, Anna, Lajic, Svetlana, Hirschberg, Angelica L, Falhammar, Henrik, Nordenström, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246868/ https://www.ncbi.nlm.nih.gov/pubmed/33346381 http://dx.doi.org/10.1111/cen.14398 |
Ejemplares similares
-
The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia
por: Ekbom, Kerstin, et al.
Publicado: (2022) -
Long-Term Outcomes of Congenital Adrenal Hyperplasia
por: Nordenström, Anna, et al.
Publicado: (2022) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020) -
Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study
por: Falhammar, Henrik, et al.
Publicado: (2021) -
Congenital adrenal hyperplasia in the Nordic countries – a potential base for long-term outcome studies
por: Nordenström, Anna, et al.
Publicado: (2023)